We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.
|Original language||English (US)|
|Number of pages||4|
|Journal||Clinical Autonomic Research|
|State||Published - Aug 22 2015|
Bibliographical notePublisher Copyright:
© 2015, Springer-Verlag Berlin Heidelberg.
- Autoimmune autonomic ganglionopathy